Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-25

Clinical Trial Update: Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major [NA]

View source ↗

Summary

A clinical trial update evaluating Al-hijamah as a treatment for beta-thalassemia major in children; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tanta University | Conditions: AL-Hijama in Thalassmia Major | NA | Status: UNKNOWN